BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8943464)

  • 1. In vivo assessments of calcium-regulated parathyroid hormone release in secondary hyperparathyroidism.
    Goodman WG; Belin TR; Salusky IB
    Kidney Int; 1996 Dec; 50(6):1834-44. PubMed ID: 8943464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
    Salusky IB; Goodman WG
    Adv Nephrol Necker Hosp; 1996; 25():289-302. PubMed ID: 8717632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.
    Indridason OS; Heath H; Khosla S; Yohay DA; Quarles LD
    Kidney Int; 1996 Nov; 50(5):1663-71. PubMed ID: 8914034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid gland function in secondary hyperparathyroidism.
    Salusky IB; Goodman WG
    Pediatr Nephrol; 1996 Jun; 10(3):359-63. PubMed ID: 8792406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method: effects of 1-year calcitriol therapy.
    Schindler S; Mannstadt M; Urena P; Segre GV; Stein G
    Clin Nephrol; 2004 Apr; 61(4):253-60. PubMed ID: 15125031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism.
    Goodman WG; Belin T; Gales B; Juppner H; Segre GV; Salusky IB
    Kidney Int; 1995 Nov; 48(5):1553-8. PubMed ID: 8544413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effect of calcium on parathyroid hormone release in adynamic renal osteodystrophy and secondary hyperparathyroidism.
    Goodman WG; Veldhuis JD; Belin TR; Juppner H; Salusky IB
    Kidney Int; 1997 May; 51(5):1590-5. PubMed ID: 9150477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-sensing by parathyroid glands in secondary hyperparathyroidism.
    Goodman WG; Veldhuis JD; Belin TR; Van Herle AJ; Juppner H; Salusky IB
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2765-72. PubMed ID: 9709944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitriol therapy and calcium-regulated PTH secretion in patients with secondary hyperparathyroidism.
    Ramirez JA; Goodman WG; Belin TR; Gales B; Segre GV; Salusky IB
    Am J Physiol; 1994 Dec; 267(6 Pt 1):E961-7. PubMed ID: 7810641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure.
    Brown EM; Wilson RE; Eastman RC; Pallotta J; Marynick SP
    J Clin Endocrinol Metab; 1982 Jan; 54(1):172-9. PubMed ID: 7054214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of secondary hyperparathyroidism.
    Slatopolsky E; Brown A; Dusso A
    Kidney Int Suppl; 1999 Dec; 73():S14-9. PubMed ID: 10633458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone immunohistochemistry in dogs with primary and secondary hyperparathyroidism: the question of adenoma and primary hyperplasia.
    van Vonderen IK; Kooistra HS; Peeters ME; Rijnberk A; van den Ingh TS
    J Comp Pathol; 2003 Jul; 129(1):61-9. PubMed ID: 12859909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of refractory secondary hyperparathyroidism.
    Rodriguez M; Canalejo A; Garfia B; Aguilera E; Almaden Y
    Kidney Int Suppl; 2002 May; (80):155-60. PubMed ID: 11982830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism.
    Costa AF; dos Reis LM; Ribeiro MC; Moysés RM; Jorgetti V
    Nephrol Dial Transplant; 2003 Apr; 18(4):743-9. PubMed ID: 12637644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure.
    Slatopolsky E; Dusso A; Brown AJ
    Am J Med Sci; 1999 Jun; 317(6):370-6. PubMed ID: 10372836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of parathyroid mass on the regulation of PTH secretion.
    Lewin E; Olgaard K
    Kidney Int Suppl; 2006 Jul; (102):S16-21. PubMed ID: 16810305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and medical treatment of secondary hyperparathyroidism.
    Fukagawa M; Kurokawa K
    Semin Surg Oncol; 1997; 13(2):73-7. PubMed ID: 9088062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro parathyroid hormone release in patients with secondary hyperparathyroidism.
    Yano S; Nomura Y; Mizoguchi H; Ogata J
    Int J Urol; 1996 Mar; 3(2):128-33. PubMed ID: 8689507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-mediated parathyroid hormone suppression to assess progression of secondary hyperparathyroidism during treatment among incident dialysis patients.
    Rodriguez M; Ureña-Torres P; Pétavy F; Cooper K; Farouk M; Goodman WG
    J Clin Endocrinol Metab; 2013 Feb; 98(2):618-25. PubMed ID: 23365129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.